Suchergebnisse - "Wabl, Chiara A"

PubPharm (14)

1

A phase Ib/II study of eribulin in combination with cyclophosphamide in patients with advanced breast cancer

enthalten in: Breast cancer research and treatment | 2024

von Gumusay, O. | Huppert, L. | Magbanua, M. | +8

2

A phase Ib/II study of eribulin in combination with cyclophosphamide in patients with advanced breast cancer

enthalten in: Breast cancer research and treatment | 2023

von Gumusay, O. | Huppert, L. | Magbanua, M. | +8

3

Advancing immunotherapy in gastroesophageal cancer through rational combinations and biomarkers

enthalten in: Immunotherapy | 2023

von Cetin, B. | Wabl, C. | Gumusay, O.

4

Should one use the combination of abiraterone and poly(ADP-ribose) polymerase inhibitors as first-line therapy for all patients with metastatic castration-resistant prostate cancer?

enthalten in: Future oncology (London, England) | 2022

von Cetin, B. | Wabl, C. | Gumusay, O.

5

Reshaping Treatment Paradigms for Advanced Renal Cell Cancer Patients and Improving Patient Management : Optimal Management for Renal Cell Cancer Patients

enthalten in: Current treatment options in oncology | 2022

von Cetin, B. | Wabl, C. | Gumusay, O.

6

CDK4/6 inhibitors : mechanisms of resistance and potential biomarkers of responsiveness in breast cancer

enthalten in: Future oncology (London, England) | 2022

von Cetin, B. | Wabl, C. | Gumusay, O.

7

Reshaping Treatment Paradigms for Advanced Renal Cell Cancer Patients and Improving Patient Management

enthalten in: Current treatment options in oncology | 2022

von Cetin, B. | Wabl, C. | Gumusay, O.

8

Reshaping Treatment Paradigms for Advanced Renal Cell Cancer Patients and Improving Patient Management

enthalten in: Current treatment options in oncology | 2022

von Cetin, B. | Wabl, C. | Gumusay, O.

9

Reshaping Treatment Paradigms for Advanced Renal Cell Cancer Patients and Improving Patient Management

enthalten in: Current treatment options in oncology | 2022

von Cetin, B. | Wabl, C. | Gumusay, O.

10

Optimal Treatment for Patients with Oligometastatic Prostate Cancer

enthalten in: Urologia internationalis | 2022

von Cetin, B. | Wabl, C. | Gumusay, O.